| Year |
Citation |
Score |
| 2014 |
Drachman DB, Kaminski HJ. Neuromuscular junction as Achilles' heel: yet another autoantibody? Neurology. 82: 1942-3. PMID 24793186 DOI: 10.1212/WNL.0000000000000486 |
0.382 |
|
| 2012 |
Sun W, Adams RN, Miagkov A, Lu Y, Juon HS, Drachman DB. Specific immunotherapy of experimental myasthenia gravis in vitro and in vivo: the Guided Missile strategy. Journal of Neuroimmunology. 251: 25-32. PMID 22769060 DOI: 10.1016/j.jneuroim.2012.06.007 |
0.306 |
|
| 2008 |
Casciola-Rosen L, Miagkov A, Nagaraju K, Askin F, Jacobson L, Rosen A, Drachman DB. Granzyme B: evidence for a role in the origin of myasthenia gravis. Journal of Neuroimmunology. 201: 33-40. PMID 18675462 DOI: 10.1016/J.Jneuroim.2008.04.041 |
0.361 |
|
| 2008 |
Drachman DB. Therapy of myasthenia gravis. Handbook of Clinical Neurology. 91: 253-72. PMID 18631846 DOI: 10.1016/S0072-9752(07)01508-4 |
0.317 |
|
| 2008 |
Drachman DB, Adams RN, Hu R, Jones RJ, Brodsky RA. Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis. Annals of the New York Academy of Sciences. 1132: 305-14. PMID 18567882 DOI: 10.1196/annals.1405.033 |
0.346 |
|
| 2004 |
Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients. Muscle & Nerve. 30: 55-60. PMID 15221879 DOI: 10.1002/mus.20069 |
0.358 |
|
| 2003 |
Drachman DB, Wu JM, Miagkov A, Williams MA, Adams RN, Wu B. Specific immunotherapy of experimental myasthenia by genetically engineered APCs: the "guided missile" strategy. Annals of the New York Academy of Sciences. 998: 520-32. PMID 14592923 DOI: 10.1196/annals.1254.068 |
0.301 |
|
| 2003 |
Miagkov A, Lobito AA, Yang B, Lopes MF, Adams RN, Palardy GR, Johnson MM, McFarland H, Lenardo MJ, Drachman DB. Production and characterization of a T cell receptor transgenic mouse recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor. Annals of the New York Academy of Sciences. 998: 379-83. PMID 14592900 DOI: 10.1196/annals.1254.045 |
0.331 |
|
| 2003 |
Drachman DB. Autonomic "myasthenia": the case for an autoimmune pathogenesis. The Journal of Clinical Investigation. 111: 797-9. PMID 12639983 DOI: 10.1172/JCI18180 |
0.352 |
|
| 2003 |
Drachman DB, Jones RJ, Brodsky RA. Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide. Annals of Neurology. 53: 29-34. PMID 12509845 DOI: 10.1002/ana.10400 |
0.347 |
|
| 2002 |
Lobito AA, Yang B, Lopes MF, Miagkov A, Adams RN, Palardy GR, Johnson MM, McFarland HI, Recher M, Drachman DB, Lenardo MJ. T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor. European Journal of Immunology. 32: 2055-67. PMID 12115627 DOI: 10.1002/1521-4141(200207)32:7<2055::AID-IMMU2055>3.0.CO;2-Q |
0.327 |
|
| 2002 |
Umapathi T, Chaudhry V, Cornblath D, Drachman D, Griffin J, Kuncl R. Head drop and camptocormia Journal of Neurology Neurosurgery and Psychiatry. 73: 1-7. PMID 12082035 DOI: 10.1136/Jnnp.73.1.1 |
0.309 |
|
| 1999 |
McIntosh KR, Drachman DB. Induction of apoptosis in activated T cell blasts by suppressive macrophages: a possible immunotherapeutic approach for treatment of autoimmune disease. Cellular Immunology. 193: 24-35. PMID 10202110 DOI: 10.1006/cimm.1998.1445 |
0.31 |
|
| 1998 |
McIntosh KR, Linsley PS, Bacha PA, Drachman DB. Immunotherapy of experimental autoimmune myasthenia gravis: selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein. Journal of Neuroimmunology. 87: 136-46. PMID 9670855 DOI: 10.1016/S0165-5728(98)00071-X |
0.355 |
|
| 1998 |
Yang B, McIntosh KR, Drachman DB. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis. Clinical Immunology and Immunopathology. 86: 45-58. PMID 9434796 DOI: 10.1006/clin.1997.4451 |
0.313 |
|
| 1996 |
Drachman DB. Immunotherapy in neuromuscular disorders: current and future strategies. Muscle & Nerve. 19: 1239-51. PMID 8808649 DOI: 10.1002/(SICI)1097-4598(199610)19:10<1239::AID-MUS1>3.0.CO;2-F |
0.318 |
|
| 1996 |
Drachman DB, Okumura S, Adams RN, McIntosh KR. Oral tolerance in myasthenia gravis. Annals of the New York Academy of Sciences. 778: 258-72. PMID 8610979 DOI: 10.1111/j.1749-6632.1996.tb21134.x |
0.337 |
|
| 1995 |
McIntosh KR, Linsley PS, Drachman DB. Immunosuppression and induction of anergy by CTLA4Ig in vitro: effects on cellular and antibody responses of lymphocytes from rats with experimental autoimmune myasthenia gravis. Cellular Immunology. 166: 103-12. PMID 7585970 DOI: 10.1006/cimm.1995.0012 |
0.331 |
|
| 1994 |
Drachman DB, Chaudhry V, Cornblath D, Kuncl RW, Pestronk A, Clawson L, Mellits ED, Quaskey S, Quinn T, Calkins A. Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation. Annals of Neurology. 35: 142-50. PMID 8109895 DOI: 10.1002/ana.410350205 |
0.309 |
|
| 1994 |
Okumura S, McIntosh K, Drachman DB. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Annals of Neurology. 36: 704-13. PMID 7979216 DOI: 10.1002/ana.410360504 |
0.371 |
|
| 1994 |
Abu-Shakra SR, Cole AJ, Adams RN, Drachman DB. Cholinergic stimulation of skeletal muscle cells induces rapid immediate early gene expression: role of intracellular calcium. Brain Research. Molecular Brain Research. 26: 55-60. PMID 7854066 DOI: 10.1016/0169-328X(94)90073-6 |
0.35 |
|
| 1993 |
Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, Miller RG, Griffin JW. Multifocal motor neuropathy: response to human immune globulin. Annals of Neurology. 33: 237-42. PMID 8498806 DOI: 10.1002/ana.410330303 |
0.348 |
|
| 1993 |
Abu-Shakra SR, Cole AJ, Drachman DB. Nerve stimulation and denervation induce differential patterns of immediate early gene mRNA expression in skeletal muscle. Brain Research. Molecular Brain Research. 18: 216-20. PMID 8497183 DOI: 10.1016/0169-328X(93)90192-R |
0.339 |
|
| 1993 |
Freimer ML, McIntosh K, Adams RA, Alving CR, Drachman DB. Gangliosides elicit a T-cell independent antibody response. Journal of Autoimmunity. 6: 281-9. PMID 8397712 DOI: 10.1006/jaut.1993.1024 |
0.323 |
|
| 1993 |
Reim J, McIntosh KR, Drachman D. Acetylcholine receptor presentation by B cells using heterobifunctional antibody conjugates. Annals of the New York Academy of Sciences. 681: 325-8. PMID 8357183 DOI: 10.1111/J.1749-6632.1993.Tb22908.X |
0.348 |
|
| 1992 |
Ramsay DA, Drachman DB, Drachman RJ, Stanley EF. Stabilization of acetylcholine receptors at the neuromuscular synapse: the role of the nerve. Brain Research. 581: 198-207. PMID 1393528 DOI: 10.1016/0006-8993(92)90709-I |
0.641 |
|
| 1992 |
McIntosh KR, Drachman DB. Tolerance to acetylcholine receptor induced by AChR-coupled syngeneic cells. Journal of Neuroimmunology. 38: 75-84. PMID 1374426 DOI: 10.1016/0165-5728(92)90092-Y |
0.342 |
|
| 1991 |
Balcer LJ, McIntosh KR, Nichols JC, Drachman DB. Suppression of immune responses to acetylcholine receptor by interleukin 2-fusion toxin: in vivo and in vitro studies. Journal of Neuroimmunology. 31: 115-22. PMID 1991819 DOI: 10.1016/0165-5728(91)90017-2 |
0.333 |
|
| 1990 |
Brooks EB, Pachner AR, Drachman DB, Kantor FS. A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis. Journal of Neuroimmunology. 28: 83-93. PMID 2341562 DOI: 10.1016/0165-5728(90)90043-M |
0.352 |
|
| 1990 |
Kahn CR, McIntosh KR, Drachman DB. T-cell vaccination in experimental myasthenia gravis: a double-edged sword. Journal of Autoimmunity. 3: 659-69. PMID 2150910 DOI: 10.1016/S0896-8411(05)80033-2 |
0.302 |
|
| 1990 |
de Silva S, McIntosh K, Blum JE, Order S, Mellits D, Drachman DB. Total lymphoid irradiation and antigen-specific tolerance: future therapy for experimental myasthenia gravis? Journal of Neuroimmunology. 29: 93-103. PMID 1698818 DOI: 10.1016/0165-5728(90)90151-C |
0.348 |
|
| 1989 |
Pestronk A, Adams RN, Cornblath D, Kuncl RW, Drachman DB, Clawson L. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Annals of Neurology. 25: 98-102. PMID 2913936 DOI: 10.1002/ana.410250118 |
0.309 |
|
| 1989 |
Crain E, McIntosh KR, Gordon G, Pestronk A, Drachman DB. The effect of thalidomide on experimental autoimmune myasthenia gravis. Journal of Autoimmunity. 2: 197-202. PMID 2788425 DOI: 10.1016/0896-8411(89)90155-8 |
0.345 |
|
| 1989 |
Pestronk A, Adams RN, Kuncl RW, Drachman DB, Clawson LL, Cornblath DR. Differential effects of prednisone and cyclophosphamide on autoantibodies in human neuromuscular disorders. Neurology. 39: 628-33. PMID 2710351 DOI: 10.1212/Wnl.39.5.628 |
0.355 |
|
| 1989 |
Drachman DB, Kuncl RW. Amyotrophic lateral sclerosis: an unconventional autoimmune disease? Annals of Neurology. 26: 269-74. PMID 2673004 DOI: 10.1002/ana.410260214 |
0.323 |
|
| 1989 |
Avila OL, Drachman DB, Pestronk A. Neurotransmission regulates stability of acetylcholine receptors at the neuromuscular junction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 9: 2902-6. PMID 2549221 DOI: 10.1523/Jneurosci.09-08-02902.1989 |
0.391 |
|
| 1989 |
Lipsky NG, Drachman DB, Pestronk A, Shih PJ. Neural regulation of mRNA for the alpha-subunit of acetylcholine receptors: role of neuromuscular transmission. Experimental Neurology. 105: 171-6. PMID 2546789 DOI: 10.1016/0014-4886(89)90116-7 |
0.367 |
|
| 1989 |
McIntosh KR, Drachman DB, Kuncl RW. Antigen-specific suppressor macrophages induced by culture with cyclosporine A plus acetylcholine receptor. Journal of Neuroimmunology. 25: 75-89. PMID 2479656 DOI: 10.1016/0165-5728(89)90088-X |
0.332 |
|
| 1989 |
Alderson K, Pestronk A, Yee WC, Drachman DB. Silver cholinesterase immunocytochemistry: a new neuromuscular junction stain. Muscle & Nerve. 12: 9-14. PMID 2473397 DOI: 10.1002/mus.880120103 |
0.318 |
|
| 1988 |
Pestronk A, Adams RN, Clawson L, Cornblath D, Kuncl RW, Griffin D, Drachman DB. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 38: 1457-61. PMID 3412595 DOI: 10.1212/Wnl.38.9.1457 |
0.316 |
|
| 1988 |
Yee WC, Drachman DB, Walser M, Pestronk A. Effect of ketoleucine treatment on atrophy of skeletal muscle. Experimental Neurology. 99: 1-9. PMID 3335234 DOI: 10.1016/0014-4886(88)90121-5 |
0.345 |
|
| 1988 |
de Silva S, Blum JE, McIntosh KR, Order S, Drachman DB. Treatment of experimental myasthenia gravis with total lymphoid irradiation. Clinical Immunology and Immunopathology. 48: 31-41. PMID 3260160 DOI: 10.1016/0090-1229(88)90154-7 |
0.339 |
|
| 1988 |
Ramsay DA, Drachman DB, Pestronk A. Rapid synthesis of acetylcholine receptors at neuromuscular junctions. Brain Research. 462: 134-41. PMID 3179729 DOI: 10.1016/0006-8993(88)90595-1 |
0.374 |
|
| 1987 |
Pestronk A, Drachman DB. Antibody-mediated membrane abnormalities in polymyositis: reduction of acetylcholine receptors by immunoglobulin. Annals of the New York Academy of Sciences. 505: 357-67. PMID 3479931 DOI: 10.1111/J.1749-6632.1987.Tb51304.X |
0.357 |
|
| 1987 |
Stanley EF, Drachman DB. Stabilization of acetylcholine receptors at neuromuscular junctions: analysis by specific antibodies. Annals of the New York Academy of Sciences. 505: 121-32. PMID 3479925 DOI: 10.1111/J.1749-6632.1987.Tb51287.X |
0.63 |
|
| 1987 |
Pestronk A, Drachman DB. Mechanism of action of lithium on acetylcholine receptor metabolism in skeletal muscle. Brain Research. 412: 302-10. PMID 3038266 DOI: 10.1016/0006-8993(87)91137-1 |
0.347 |
|
| 1987 |
McIntosh KR, Drachman DB. Properties of suppressor cells induced to acetylcholine receptor using cyclosporin A. Annals of the New York Academy of Sciences. 505: 628-38. PMID 2961298 DOI: 10.1111/J.1749-6632.1987.Tb51332.X |
0.319 |
|
| 1986 |
Kuncl RW, Pestronk A, Drachman DB, Rechthand E. The pathophysiology of penicillamine-induced myasthenia gravis. Annals of Neurology. 20: 740-4. PMID 3813503 DOI: 10.1002/ana.410200617 |
0.384 |
|
| 1986 |
Stanley EF, Drachman DB. The effects of nerve section on the non-quantal release of ACh from the motor nerve terminal. Brain Research. 365: 289-92. PMID 3004659 DOI: 10.1016/0006-8993(86)91640-9 |
0.604 |
|
| 1986 |
McIntosh KR, Drachman DB. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis. Science (New York, N.Y.). 232: 401-3. PMID 2938256 DOI: 10.1126/Science.2938256 |
0.35 |
|
| 1985 |
Kuncl RW, Drachman DB, Kishimoto Y. Phospholipid methylation in skeletal muscle membranes. Muscle & Nerve. 8: 426-34. PMID 16758590 DOI: 10.1002/Mus.880080513 |
0.303 |
|
| 1985 |
Pestronk A, Drachman DB, Self SG. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates. Muscle & Nerve. 8: 245-51. PMID 4058469 DOI: 10.1002/Mus.880080311 |
0.364 |
|
| 1985 |
Pestronk A, Drachman DB. Polymyositis: reduction of acetylcholine receptors in skeletal muscle. Muscle & Nerve. 8: 233-9. PMID 4058467 DOI: 10.1002/mus.880080309 |
0.377 |
|
| 1985 |
Pestronk A, Teoh R, Sims C, Drachman DB. Effects of dimethyl sulfoxide on humoral immune responses to acetylcholine receptors in the rat. Clinical Immunology and Immunopathology. 37: 172-8. PMID 3876185 DOI: 10.1016/0090-1229(85)90148-5 |
0.329 |
|
| 1985 |
Pestronk A, Drachman DB. Motor nerve terminal outgrowth and acetylcholine receptors: inhibition of terminal outgrowth by alpha-bungarotoxin and anti-acetylcholine receptor antibody. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 5: 751-8. PMID 3871842 DOI: 10.1523/Jneurosci.05-03-00751.1985 |
0.386 |
|
| 1985 |
Drachman DB, Adams RN, McIntosh K, Pestronk A. Treatment of experimental myasthenia gravis with cyclosporin A. Clinical Immunology and Immunopathology. 34: 174-88. PMID 3871377 DOI: 10.1016/0090-1229(85)90022-4 |
0.371 |
|
| 1984 |
Andrew CG, Drachman DB, Pestronk A, Narayan O. Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulinum toxin and denervation. Science (New York, N.Y.). 223: 714-6. PMID 6320369 DOI: 10.1126/Science.6320369 |
0.329 |
|
| 1983 |
Elias SB, Appel SH, Lennon VA, Jones G, Howard F, Elveback L, Drachman DB, Adams RN, Josifek LF, Self SG. Autoantibodies to Acetylcholine Receptors in Myasthenia Gravis The New England Journal of Medicine. 308: 402-403. PMID 6823248 DOI: 10.1056/Nejm198302173080718 |
0.346 |
|
| 1983 |
Stanley EF, Drachman DB. Rapid degradation of "new" acetylcholine receptors at neuromuscular junctions. Science (New York, N.Y.). 222: 67-9. PMID 6623057 DOI: 10.1126/Science.6623057 |
0.633 |
|
| 1983 |
Pestronk A, Drachman DB, Teoh R, Adams RN. Combined short-term immunotherapy for experimental autoimmune myasthenia gravis. Annals of Neurology. 14: 235-41. PMID 6354071 DOI: 10.1002/ana.410140210 |
0.341 |
|
| 1983 |
Stanley EF, Drachman DB. Botulinum toxin blocks quantal but not non-quantal release of ACh at the neuromuscular junction. Brain Research. 261: 172-5. PMID 6301625 DOI: 10.1016/0006-8993(83)91300-8 |
0.586 |
|
| 1983 |
Drachman DB. Myasthenia gravis: immunobiology of a receptor disorder Trends in Neurosciences. 6: 446-451. DOI: 10.1016/0166-2236(83)90216-3 |
0.361 |
|
| 1982 |
Drachman DB, Adams RN, Josifek LF, Self SG. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. The New England Journal of Medicine. 307: 769-75. PMID 7110241 DOI: 10.1056/Nejm198209233071301 |
0.411 |
|
| 1982 |
Stewart PM, Walser M, Drachman DB. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy. Muscle & Nerve. 5: 197-201. PMID 7088016 DOI: 10.1002/mus.880050304 |
0.319 |
|
| 1982 |
Pestronk A, Drachman DB, Adams RN. Treatment of ongoing experimental myasthenia gravis with short term high dose cyclophosphamide. Muscle & Nerve. 5: 79-84. PMID 6977088 DOI: 10.1002/mus.880050115 |
0.374 |
|
| 1982 |
Drachman DB, Stanley EF, Pestronk A, Griffin JW, Price DL. Neurotrophic regulation of two properties of skeletal muscle by impulse-dependent and spontaneous acetylcholine transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 2: 232-43. PMID 6278104 DOI: 10.1523/Jneurosci.02-02-00232.1982 |
0.654 |
|
| 1981 |
Stanley EF, Drachman DB. Denervation accelerates the degradation of junctional acetylcholine receptors. Experimental Neurology. 73: 390-6. PMID 7262244 DOI: 10.1016/0014-4886(81)90274-0 |
0.611 |
|
| 1981 |
Drachman DB, Adams RN, Josifek LF, Pestronk A, Stanley EF. Antibody-mediated mechanisms of ACh receptor loss in myasthenia gravis: clinical relevance. Annals of the New York Academy of Sciences. 377: 175-88. PMID 6951471 DOI: 10.1111/J.1749-6632.1981.Tb33731.X |
0.628 |
|
| 1980 |
Pestronk A, Drachman DB. Dimethyl sulphoxide reduces anti-receptor antibody titres in experimental myasthenia gravis. Nature. 288: 733-4. PMID 7453805 DOI: 10.1038/288733a0 |
0.377 |
|
| 1980 |
Pestronk A, Drachman DB. Lithium reduces the number of acetylcholine receptors in skeletal muscle. Science (New York, N.Y.). 210: 342-3. PMID 7423198 DOI: 10.1126/Science.7423198 |
0.397 |
|
| 1980 |
Pestronk A, Drachman DB, Griffin JW. Effects of aging on nerve sprouting and regeneration. Experimental Neurology. 70: 65-82. PMID 7418774 DOI: 10.1016/0014-4886(80)90006-0 |
0.302 |
|
| 1980 |
Murphy A, Drachman DB, Satya-Murti S, Pestronk A, Eggleston JC. Critical reexamination of the thymus immunization model of myasthenia gravis. Muscle & Nerve. 3: 293-7. PMID 7412773 DOI: 10.1002/mus.880030404 |
0.334 |
|
| 1980 |
Stanley EF, Drachman DB. Denervation and the time course of resting membrane potential changes in skeletal muscle in vivo. Experimental Neurology. 69: 253-9. PMID 7409044 DOI: 10.1016/0014-4886(80)90209-5 |
0.63 |
|
| 1980 |
Noguchi SA, Drachman DB, Adams RN, Hirsch RL. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis. Annals of Neurology. 8: 32-7. PMID 7406445 DOI: 10.1002/ana.410080105 |
0.328 |
|
| 1980 |
Pestronk A, Drachman DB, Stanley EF, Price DL, Griffin JW. Cholinergic transmission regulates extrajunctional acetylcholine receptors. Experimental Neurology. 70: 690-6. PMID 6254793 DOI: 10.1016/0014-4886(80)90193-4 |
0.646 |
|
| 1980 |
Drachman DB, Adams RN, Stanley EF, Pestronk A. Mechanisms of acetylcholine receptor loss in myasthenia gravis. Journal of Neurology, Neurosurgery, and Psychiatry. 43: 601-10. PMID 6249894 DOI: 10.1136/jnnp.43.7.601 |
0.644 |
|
| 1980 |
Pestronk A, Drachman DB, Stanley EF, Adams RN. Treatment of experimental autoimmune myasthenia gravis (EAMG) using single, high-dose cyclophosphamide Neurology. 30: MG 6. |
0.533 |
|
| 1979 |
Jackson DL, Satya-Murti S, Davis L, Drachman DB. Isaacs syndrome with laryngeal involvement: an unusual presentation of myokymia. Neurology. 29: 1612-5. PMID 574225 DOI: 10.1212/WNL.29.12.1612 |
0.344 |
|
| 1979 |
Drachman DB. Acetylcholine receptors and myasthenia gravis. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 162: 26-30. PMID 504236 DOI: 10.3181/00379727-162-40611 |
0.409 |
|
| 1979 |
Stanley EF, Drachman DB. Effect of disuse on the resting membrane potential of skeletal muscle. Experimental Neurology. 64: 231-4. PMID 428496 DOI: 10.1016/0014-4886(79)90018-9 |
0.599 |
|
| 1979 |
Drachman DB, Pestronk A, Stanley EF. Pathogenesis of myasthenia gravis as a disorder of acetylcholine receptors. Advances in Cytopharmacology. 3: 237-44. PMID 382787 |
0.567 |
|
| 1979 |
DRACHMAN DB. Nerve-Muscle Interaction Neurology. 29: 1441-1441. DOI: 10.1212/WNL.29.10.1441-a |
0.32 |
|
| 1978 |
Stanley EF, Drachman DB. Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Science (New York, N.Y.). 200: 1285-7. PMID 663610 DOI: 10.1126/Science.663610 |
0.648 |
|
| 1978 |
Drachman DB, Angus CW, Adams RN, Michelson JD, Hoffman GJ. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. The New England Journal of Medicine. 298: 1116-22. PMID 643030 DOI: 10.1056/NEJM197805182982004 |
0.395 |
|
| 1978 |
Drachman DB, Angus CW, Adams RN, Kao I. Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation process. Proceedings of the National Academy of Sciences of the United States of America. 75: 3422-6. PMID 277944 |
0.308 |
|
| 1978 |
Pestronk A, Drachman DB. Motor nerve sprouting and acetylcholine receptors. Science (New York, N.Y.). 199: 1223-5. PMID 204007 DOI: 10.1126/Science.204007 |
0.379 |
|
| 1977 |
Kao I, Drachman DB. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science (New York, N.Y.). 196: 527-9. PMID 850793 DOI: 10.1126/Science.850793 |
0.392 |
|
| 1977 |
Kao I, Drachman DB. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science (New York, N.Y.). 195: 74-5. PMID 831257 DOI: 10.1126/Science.831257 |
0.395 |
|
| 1977 |
Toyka KV, Drachman DB, Griffin DE, Pestronk A, Winkelstein JA, Fishbeck KH, Kao I. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. The New England Journal of Medicine. 296: 125-31. PMID 831074 DOI: 10.1056/Nejm197701202960301 |
0.363 |
|
| 1976 |
Toyka KV, Drachman DB, Pestronk A, Fischbeck KH, Kao I. [A transferable "Myasthenogenic" factor in the serum of patients with myasthenia gravis.]. Journal of Neurology. 212: 271-80. PMID 20563776 DOI: 10.1007/BF00314528 |
0.345 |
|
| 1976 |
Drachman DB, Weiner LP, Price DL, Chase J. Experimental arthrogryposis caused by viral myopathy. Archives of Neurology. 33: 362-7. PMID 1267622 DOI: 10.1001/archneur.1976.00500050048009 |
0.301 |
|
| 1976 |
Freeman SS, Engel AG, Drachman DB. Experimental acetylcholine blockade of the neuromuscular junction. Effects on end plate and muscle fiber ultrastructure. Annals of the New York Academy of Sciences. 274: 46-59. PMID 1066994 DOI: 10.1111/J.1749-6632.1976.Tb47675.X |
0.349 |
|
| 1976 |
Drachman DB, Fambrough DM. Are muscle fibers denervated in myotonic dystrophy? Archives of Neurology. 33: 485-8. PMID 938274 DOI: 10.1001/archneur.1976.00500070027005 |
0.37 |
|
| 1976 |
Kao I, Drachman DB, Price DL. Botulinum toxin: mechanism of presynaptic blockade. Science (New York, N.Y.). 193: 1256-8. PMID 785600 DOI: 10.1126/Science.785600 |
0.322 |
|
| 1976 |
Pestronk A, Drachman DB, Griffin JW. Effect of botulinum toxin on trophic regulation of acetylcholine receptors. Nature. 264: 787-9. PMID 64930 DOI: 10.1038/264787a0 |
0.423 |
|
| 1976 |
Pestronk A, Drachman DB, Griffin JW. Effect of muscle disuse on acetylcholine receptors. Nature. 260: 352-3. PMID 56718 DOI: 10.1038/260352a0 |
0.391 |
|
| 1975 |
Satyamurti S, Drachman DB, Slone F. Blockade of acetylcholine receptors: a model of myasthenia gravis. Science (New York, N.Y.). 187: 955-7. PMID 1145181 DOI: 10.1126/Science.1145181 |
0.381 |
|
| 1973 |
Fambrough DM, Drachman DB, Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science (New York, N.Y.). 182: 293-5. PMID 4742736 DOI: 10.1126/Science.182.4109.293 |
0.395 |
|
| 1972 |
Drachman DB, Witzke F. Trophic regulation of acetylcholine sensitivity of muscle: effect of electrical stimulation. Science (New York, N.Y.). 176: 514-6. PMID 5032352 DOI: 10.1126/Science.176.4034.514 |
0.331 |
|
| 1971 |
Drachman DB, Singer M. Regeneration in botulinum-poisoned forelimbs of the newt, Triturus. Experimental Neurology. 32: 1-11. PMID 4328788 DOI: 10.1016/0014-4886(71)90159-2 |
0.346 |
|
| 1970 |
Drachman DB, Romanul FC. Effect of neuromuscular blockade on enzymatic activities of muscles. Archives of Neurology. 23: 85-9. PMID 4246349 DOI: 10.1001/archneur.1970.00480250089013 |
0.323 |
|
| Show low-probability matches. |